|
OMIM |
Link |
Information gain |
01 |
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000916944
|
|
|
HSCR5
|
[NCBI]
|
0.000916944
|
|
|
OTSC4
|
[NCBI]
|
0.000916944
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.000916944
|
|
|
FEB7
|
[NCBI]
|
0.000916944
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000916944
|
|
|
DFNA25
|
[NCBI]
|
0.000916944
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000916944
|
|
|
FEB9
|
[NCBI]
|
0.000916944
|
|
|
STHAG5
|
[NCBI]
|
0.000916944
|
|
|
glioma, familial, 1
|
[NCBI]
|
0.000916944
|
|
|
ATFB2
|
[NCBI]
|
0.000916944
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000916944
|
|
|
FEB1
|
[NCBI]
|
0.000786299
|
|
|
leber optic atrophy
|
[NCBI]
|
0.000733313
|
|
|
HDL3
|
[NCBI]
|
0.000653307
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.000653307
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000653307
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.000653307
|
|
|
HCFP2
|
[NCBI]
|
0.000653307
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.000653307
|
|
|
MCOPCB2
|
[NCBI]
|
0.000653307
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000653307
|
|
|
acne inversa, familial
|
[NCBI]
|
0.000653307
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000653307
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000653307
|
|
|
MACOM
|
[NCBI]
|
0.000653307
|
|
|
OFC2
|
[NCBI]
|
0.000554783
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000554783
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000554783
|
|
|
IDDM13
|
[NCBI]
|
0.000554783
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.000554783
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000554783
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000554783
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000525374
|
|
|
MPD2
|
[NCBI]
|
0.000491355
|
|
|
dupuytren contracture
|
[NCBI]
|
0.000491355
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.000491355
|
|
|
PTOS1
|
[NCBI]
|
0.000491355
|
|
|
spinal muscular atrophy, distal, congenital nonprogressive
|
[NCBI]
|
0.000491355
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.000491355
|
|
|
DYT6
|
[NCBI]
|
0.000491355
|
|
|
amyotrophy, neurogenic scapuloperoneal, new england type
|
[NCBI]
|
0.000491355
|
|
|
DYX3
|
[NCBI]
|
0.000491355
|
|
|
CHDM
|
[NCBI]
|
0.000491355
|
|
|
RA
|
[NCBI]
|
0.000450308
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000444596
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.000444596
|
|
|
USH2B
|
[NCBI]
|
0.000444596
|
|
|
SPG12
|
[NCBI]
|
0.000444596
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.000444596
|
|
|
HMN7A
|
[NCBI]
|
0.000407654
|
|
|
EKD2
|
[NCBI]
|
0.000407654
|
|
|
actinic prurigo
|
[NCBI]
|
0.000407654
|
|
|
FSHMD1A
|
[NCBI]
|
0.00038753
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.0003772
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.0003772
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.0003772
|
|
|
SHFLD1
|
[NCBI]
|
0.000309242
|
|
|
VWS
|
[NCBI]
|
0.000276495
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000248298
|
|
|
DURS1
|
[NCBI]
|
0.000236203
|
|
|
PAND1
|
[NCBI]
|
0.000236203
|
|
|
IGAD1
|
[NCBI]
|
0.000225022
|
|
|
SHFM3
|
[NCBI]
|
0.000204963
|
|
|
HSCR1
|
[NCBI]
|
0.000189871
|
|
|
chiari malformation type i
|
[NCBI]
|
0.000187422
|
|
|
VUR1
|
[NCBI]
|
0.000187422
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
0.000166318
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000164792
|
|
|
MAFD1
|
[NCBI]
|
0.000163122
|
|
|
FCAS
|
[NCBI]
|
0.000160814
|
|
|
MAFD6
|
[NCBI]
|
0.000156931
|
|
|
AOS
|
[NCBI]
|
0.000151667
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.000145597
|
|
|
CCM
|
[NCBI]
|
0.000139258
|
|
|
RP11
|
[NCBI]
|
0.000138771
|
|
|
HTX1
|
[NCBI]
|
0.000138771
|
|
|
LRRK2
|
[NCBI]
|
0.000134049
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000129071
|
|
|
ADLTE
|
[NCBI]
|
0.000125442
|
|
|
muckle-wells syndrome
|
[NCBI]
|
0.000125442
|
|
|
HFE
|
[NCBI]
|
0.000124059
|
|
|
CF
|
[NCBI]
|
0.000122351
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
0.000121362
|
|
|
sclerocornea, autosomal dominant
|
[NCBI]
|
0.000121362
|
|
|
cephalocele, atretic
|
[NCBI]
|
0.000121362
|
|
|
short stature, pituitary and cerebellar defects, and small sella turcica
|
[NCBI]
|
0.000121362
|
|
|
RB1
|
[NCBI]
|
0.000114421
|
|
|
DRD
|
[NCBI]
|
0.000107683
|
|
|
ATXN8OS
|
[NCBI]
|
0.00010407
|
|
|
MTRNR1
|
[NCBI]
|
9.98985e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
9.36351e-05
|
|
|
CC
|
[NCBI]
|
9.36351e-05
|
|
|
DFNA23
|
[NCBI]
|
9.36351e-05
|
|
|
ASD2
|
[NCBI]
|
9.36351e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
9.36351e-05
|
|
|
MCOPS5
|
[NCBI]
|
9.36351e-05
|
|
|
craniosynostosis with ectopia lentis
|
[NCBI]
|
9.36351e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
9.19406e-05
|
|
|
keloids
|
[NCBI]
|
8.31988e-05
|
|
|
CMD1J
|
[NCBI]
|
8.31988e-05
|
|
|
moved to 310600
|
[NCBI]
|
8.31988e-05
|
|
|
EDMD3
|
[NCBI]
|
8.31988e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
8.31988e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
8.31988e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
8.31988e-05
|
|
|
BOS3
|
[NCBI]
|
8.31988e-05
|
|
|
DDU
|
[NCBI]
|
8.31988e-05
|
|
|
DYT1
|
[NCBI]
|
8.09226e-05
|
|
|
BRRS
|
[NCBI]
|
7.8419e-05
|
|
|
EKD1
|
[NCBI]
|
7.78025e-05
|
|
|
clubfoot
|
[NCBI]
|
7.64379e-05
|
|
|
AIS1
|
[NCBI]
|
7.64379e-05
|
|
|
SCA13
|
[NCBI]
|
7.64379e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
7.64379e-05
|
|
|
corneal fleck dystrophy
|
[NCBI]
|
7.64379e-05
|
|
|
BRCA1
|
[NCBI]
|
7.22058e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
7.14225e-05
|
|
|
CMD1D
|
[NCBI]
|
7.14225e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
7.14225e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
7.14225e-05
|
|
|
NAIC
|
[NCBI]
|
7.14225e-05
|
|
|
TCOF
|
[NCBI]
|
7.05036e-05
|
|
|
prostate cancer
|
[NCBI]
|
6.98651e-05
|
|
|
MEFV
|
[NCBI]
|
6.94823e-05
|
|
|
SPG4
|
[NCBI]
|
6.78702e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
6.74352e-05
|
|
|
CMD1E
|
[NCBI]
|
6.74352e-05
|
|
|
HPE4
|
[NCBI]
|
6.74352e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
6.56982e-05
|
|
|
BRCA2
|
[NCBI]
|
6.53089e-05
|
|
|
SPMM
|
[NCBI]
|
6.41273e-05
|
|
|
CZP3
|
[NCBI]
|
6.41273e-05
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
6.41273e-05
|
|
|
IDDM5
|
[NCBI]
|
6.41273e-05
|
|
|
VMCM
|
[NCBI]
|
6.13022e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
6.13022e-05
|
|
|
mast cell disease
|
[NCBI]
|
6.13022e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
6.13022e-05
|
|
|
IDD
|
[NCBI]
|
6.13022e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
6.13022e-05
|
|
|
HMN2A
|
[NCBI]
|
5.88381e-05
|
|
|
CMT2D
|
[NCBI]
|
5.88381e-05
|
|
|
CMH4
|
[NCBI]
|
5.88381e-05
|
|
|
LISX1
|
[NCBI]
|
5.66542e-05
|
|
|
GVM
|
[NCBI]
|
5.46942e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
5.46942e-05
|
|
|
MCOPS3
|
[NCBI]
|
5.46942e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
5.46942e-05
|
|
|
CMT2A2
|
[NCBI]
|
5.46942e-05
|
|
|
OCD1
|
[NCBI]
|
5.46942e-05
|
|
|
ZIC3
|
[NCBI]
|
5.39512e-05
|
|
|
LIS1
|
[NCBI]
|
5.29172e-05
|
|
|
CMT4A
|
[NCBI]
|
5.29172e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
5.29172e-05
|
|
|
CMT2B
|
[NCBI]
|
5.29172e-05
|
|
|
HPE2
|
[NCBI]
|
5.29172e-05
|
|
|
ALPS
|
[NCBI]
|
5.13477e-05
|
|
|
CMT2A1
|
[NCBI]
|
5.12925e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
5.06987e-05
|
|
|
SCZD
|
[NCBI]
|
5.06313e-05
|
|
|
OFC1
|
[NCBI]
|
5.03034e-05
|
|
|
MYBPC3
|
[NCBI]
|
5.02702e-05
|
|
|
STGD3
|
[NCBI]
|
4.97966e-05
|
|
|
HMN5
|
[NCBI]
|
4.97966e-05
|
|
|
SCZD9
|
[NCBI]
|
4.97966e-05
|
|
|
JME
|
[NCBI]
|
4.97966e-05
|
|
|
BHD
|
[NCBI]
|
4.97966e-05
|
|
|
esophageal cancer
|
[NCBI]
|
4.84112e-05
|
|
|
BHC
|
[NCBI]
|
4.84112e-05
|
|
|
SCZD4
|
[NCBI]
|
4.84112e-05
|
|
|
HPE3
|
[NCBI]
|
4.84112e-05
|
|
|
MYOC
|
[NCBI]
|
4.77291e-05
|
|
|
SMS
|
[NCBI]
|
4.75974e-05
|
|
|
SGCE
|
[NCBI]
|
4.74712e-05
|
|
|
PRKCG
|
[NCBI]
|
4.74712e-05
|
|
|
PFIC1
|
[NCBI]
|
4.71213e-05
|
|
|
HSAN2
|
[NCBI]
|
4.71213e-05
|
|
|
FMF
|
[NCBI]
|
4.70211e-05
|
|
|
DCX
|
[NCBI]
|
4.62879e-05
|
|
|
HPC1
|
[NCBI]
|
4.59152e-05
|
|
|
acromegaly
|
[NCBI]
|
4.59152e-05
|
|
|
BBS
|
[NCBI]
|
4.54295e-05
|
|
|
CYP1B1
|
[NCBI]
|
4.52132e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
4.47828e-05
|
|
|
EA2
|
[NCBI]
|
4.47828e-05
|
|
|
FHM2
|
[NCBI]
|
4.47828e-05
|
|
|
HIDS
|
[NCBI]
|
4.3716e-05
|
|
|
GEFS+
|
[NCBI]
|
4.3716e-05
|
|
|
CBAVD
|
[NCBI]
|
4.3716e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
4.3716e-05
|
|
|
MVK
|
[NCBI]
|
4.33214e-05
|
|
|
SCA10
|
[NCBI]
|
4.27079e-05
|
|
|
PRSS1
|
[NCBI]
|
4.24793e-05
|
|
|
UCMD
|
[NCBI]
|
4.17525e-05
|
|
|
MSH6
|
[NCBI]
|
4.1694e-05
|
|
|
PNKD1
|
[NCBI]
|
3.8368e-05
|
|
|
ODDD
|
[NCBI]
|
3.8368e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
3.81266e-05
|
|
|
HNFJ
|
[NCBI]
|
3.76132e-05
|
|
|
LCA1
|
[NCBI]
|
3.76132e-05
|
|
|
FHM1
|
[NCBI]
|
3.68893e-05
|
|
|
TNFRSF6
|
[NCBI]
|
3.65631e-05
|
|
|
testicular tumors
|
[NCBI]
|
3.5525e-05
|
|
|
graves disease
|
[NCBI]
|
3.48809e-05
|
|
|
PSEN2
|
[NCBI]
|
3.43538e-05
|
|
|
SPG4
|
[NCBI]
|
3.25204e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
3.19779e-05
|
|
|
MYOZ2
|
[NCBI]
|
3.16686e-05
|
|
|
CYP2C18
|
[NCBI]
|
3.16686e-05
|
|
|
OPA1
|
[NCBI]
|
3.14522e-05
|
|
|
GCPS
|
[NCBI]
|
3.14522e-05
|
|
|
LFS1
|
[NCBI]
|
3.09424e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
3.09424e-05
|
|
|
TRPS2
|
[NCBI]
|
2.99673e-05
|
|
|
VHL
|
[NCBI]
|
2.96528e-05
|
|
|
TSNAX
|
[NCBI]
|
2.96513e-05
|
|
|
KIF14
|
[NCBI]
|
2.96513e-05
|
|
|
GPD1L
|
[NCBI]
|
2.96513e-05
|
|
|
VMD
|
[NCBI]
|
2.81741e-05
|
|
|
SP4
|
[NCBI]
|
2.81524e-05
|
|
|
PIP5K3
|
[NCBI]
|
2.81524e-05
|
|
|
KCNC3
|
[NCBI]
|
2.81524e-05
|
|
|
GLMN
|
[NCBI]
|
2.81524e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
2.7755e-05
|
|
|
LMNA
|
[NCBI]
|
2.77123e-05
|
|
|
SCS
|
[NCBI]
|
2.73464e-05
|
|
|
PLUNC
|
[NCBI]
|
2.69587e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.6948e-05
|
|
|
SCA6
|
[NCBI]
|
2.6948e-05
|
|
|
EGF
|
[NCBI]
|
2.6806e-05
|
|
|
FBN1
|
[NCBI]
|
2.65519e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
2.61798e-05
|
|
|
PPARG
|
[NCBI]
|
2.60625e-05
|
|
|
HRPT2
|
[NCBI]
|
2.59668e-05
|
|
|
FBXO15
|
[NCBI]
|
2.59668e-05
|
|
|
LHX4
|
[NCBI]
|
2.59668e-05
|
|
|
obesity
|
[NCBI]
|
2.58092e-05
|
|
|
ATM
|
[NCBI]
|
2.5779e-05
|
|
|
AN2
|
[NCBI]
|
2.54471e-05
|
|
|
CDKN2A
|
[NCBI]
|
2.51451e-05
|
|
|
TARDBP
|
[NCBI]
|
2.51183e-05
|
|
|
PSTPIP1
|
[NCBI]
|
2.51183e-05
|
|
|
SCA7
|
[NCBI]
|
2.50932e-05
|
|
|
RET
|
[NCBI]
|
2.4714e-05
|
|
|
COL9A2
|
[NCBI]
|
2.4377e-05
|
|
|
CACNB4
|
[NCBI]
|
2.4377e-05
|
|
|
hemojuvelin
|
[NCBI]
|
2.4377e-05
|
|
|
MAF
|
[NCBI]
|
2.4377e-05
|
|
|
MFS
|
[NCBI]
|
2.43631e-05
|
|
|
BBS4
|
[NCBI]
|
2.37189e-05
|
|
|
EYA4
|
[NCBI]
|
2.37189e-05
|
|
|
ATP8B1
|
[NCBI]
|
2.37189e-05
|
|
|
TTC10
|
[NCBI]
|
2.37189e-05
|
|
|
AIP
|
[NCBI]
|
2.37189e-05
|
|
|
ELOVL4
|
[NCBI]
|
2.37189e-05
|
|
|
MTTI
|
[NCBI]
|
2.31272e-05
|
|
|
MDM1
|
[NCBI]
|
2.31272e-05
|
|
|
BRIP1
|
[NCBI]
|
2.25899e-05
|
|
|
BFSP2
|
[NCBI]
|
2.25899e-05
|
|
|
FLCN
|
[NCBI]
|
2.25899e-05
|
|
|
RDT
|
[NCBI]
|
2.25216e-05
|
|
|
PSEN1
|
[NCBI]
|
2.21023e-05
|
|
|
CLCN7
|
[NCBI]
|
2.20978e-05
|
|
|
SIX3
|
[NCBI]
|
2.20978e-05
|
|
|
OTX2
|
[NCBI]
|
2.20978e-05
|
|
|
SIX1
|
[NCBI]
|
2.20978e-05
|
|
|
apc gene
|
[NCBI]
|
2.17767e-05
|
|
|
porphyria variegata
|
[NCBI]
|
2.16602e-05
|
|
|
SVAS
|
[NCBI]
|
2.16602e-05
|
|
|
TPM1
|
[NCBI]
|
2.1644e-05
|
|
|
RAI1
|
[NCBI]
|
2.1644e-05
|
|
|
SMARCB1
|
[NCBI]
|
2.1223e-05
|
|
|
CDK4
|
[NCBI]
|
2.10344e-05
|
|
|
SPG3A
|
[NCBI]
|
2.08304e-05
|
|
|
IRF6
|
[NCBI]
|
2.04626e-05
|
|
|
ATP1A2
|
[NCBI]
|
2.04626e-05
|
|
|
ELAC2
|
[NCBI]
|
2.04626e-05
|
|
|
BEST1
|
[NCBI]
|
2.04626e-05
|
|
|
GJA3
|
[NCBI]
|
1.97903e-05
|
|
|
MUTYH
|
[NCBI]
|
1.94814e-05
|
|
|
FLT4
|
[NCBI]
|
1.94814e-05
|
|
|
KRIT1
|
[NCBI]
|
1.94814e-05
|
|
|
NEU1
|
[NCBI]
|
1.91881e-05
|
|
|
CHRNA4
|
[NCBI]
|
1.91881e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
1.91101e-05
|
|
|
SCA2
|
[NCBI]
|
1.91101e-05
|
|
|
breast cancer
|
[NCBI]
|
1.88786e-05
|
|
|
GATA4
|
[NCBI]
|
1.86427e-05
|
|
|
HD
|
[NCBI]
|
1.83725e-05
|
|
|
MFN2
|
[NCBI]
|
1.81446e-05
|
|
|
CLOCK
|
[NCBI]
|
1.79108e-05
|
|
|
SLC3A1
|
[NCBI]
|
1.79108e-05
|
|
|
SCN1A
|
[NCBI]
|
1.76863e-05
|
|
|
HTR2A
|
[NCBI]
|
1.76863e-05
|
|
|
OPA1
|
[NCBI]
|
1.74702e-05
|
|
|
DYT1
|
[NCBI]
|
1.72619e-05
|
|
|
PRKAR1A
|
[NCBI]
|
1.72619e-05
|
|
|
TNNT2
|
[NCBI]
|
1.72619e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.72619e-05
|
|
|
APEX
|
[NCBI]
|
1.7061e-05
|
|
|
DISC1
|
[NCBI]
|
1.6867e-05
|
|
|
TGFBR2
|
[NCBI]
|
1.66793e-05
|
|
|
TWIST1
|
[NCBI]
|
1.66793e-05
|
|
|
RBP4
|
[NCBI]
|
1.66793e-05
|
|
|
TP53
|
[NCBI]
|
1.65309e-05
|
|
|
GLI3
|
[NCBI]
|
1.64977e-05
|
|
|
PAFAH1B1
|
[NCBI]
|
1.61509e-05
|
|
|
PPOX
|
[NCBI]
|
1.59852e-05
|
|
|
APS1
|
[NCBI]
|
1.56329e-05
|
|
|
STK11
|
[NCBI]
|
1.50819e-05
|
|
|
CD
|
[NCBI]
|
1.49347e-05
|
|
|
TCF7L2
|
[NCBI]
|
1.41846e-05
|
|
|
TSC1
|
[NCBI]
|
1.41846e-05
|
|
|
TNF
|
[NCBI]
|
1.405e-05
|
|
|
VHL
|
[NCBI]
|
1.38012e-05
|
|
|
SCN5A
|
[NCBI]
|
1.36223e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.3199e-05
|
|
|
SLC11A1
|
[NCBI]
|
1.28276e-05
|
|
|
MTND4
|
[NCBI]
|
1.27359e-05
|
|
|
ELN
|
[NCBI]
|
1.2384e-05
|
|
|
CTNNB1
|
[NCBI]
|
1.21344e-05
|
|
|
MC4R
|
[NCBI]
|
1.18186e-05
|
|
|
PAX6
|
[NCBI]
|
1.15935e-05
|
|
|
BMP2
|
[NCBI]
|
1.13775e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.11027e-05
|
|
|
HNF1A
|
[NCBI]
|
1.04137e-05
|
|
|
MEN1
|
[NCBI]
|
1.03553e-05
|
|
|
CFTR
|
[NCBI]
|
9.77905e-06
|
|
|
GNAS
|
[NCBI]
|
9.75401e-06
|
|
|
MC1R
|
[NCBI]
|
9.65191e-06
|
|
|
EIG
|
[NCBI]
|
9.50573e-06
|
|
|
AD
|
[NCBI]
|
9.29226e-06
|
|
|
MAPT
|
[NCBI]
|
8.81606e-06
|
|
|
TS
|
[NCBI]
|
8.16516e-06
|
|
|
DRPLA
|
[NCBI]
|
8.07568e-06
|
|
|
PTEN
|
[NCBI]
|
7.67887e-06
|
|
|
FGFR2
|
[NCBI]
|
7.35335e-06
|
|
|
PJS
|
[NCBI]
|
7.00402e-06
|
|
|
APP
|
[NCBI]
|
6.96195e-06
|
|
|
TTR
|
[NCBI]
|
6.75339e-06
|
|
|
GJB2
|
[NCBI]
|
6.62852e-06
|
|
|
PMP22
|
[NCBI]
|
6.36867e-06
|
|
|
PRNP
|
[NCBI]
|
6.0526e-06
|
|
|
CPI
|
[NCBI]
|
4.99779e-06
|
|
|
SHH
|
[NCBI]
|
4.76297e-06
|
|
|
PD
|
[NCBI]
|
4.21462e-06
|
|
|
CP
|
[NCBI]
|
4.07673e-06
|
|
|
PCNA
|
[NCBI]
|
3.91188e-06
|
|
|
LDLR
|
[NCBI]
|
3.85834e-06
|
|
|
MODY
|
[NCBI]
|
3.75852e-06
|
|
|
GJA1
|
[NCBI]
|
3.72864e-06
|
|
|
RASA1
|
[NCBI]
|
3.70329e-06
|
|
|
CVID
|
[NCBI]
|
2.2889e-06
|
|
|
APC
|
[NCBI]
|
2.11391e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.86333e-06
|
|
|
RP
|
[NCBI]
|
1.66371e-06
|
|
|
GTS
|
[NCBI]
|
8.8591e-07
|
|
|
CD
|
[NCBI]
|
7.29289e-07
|
|
|
GDNF
|
[NCBI]
|
3.34295e-07
|
|
|
CRC
|
[NCBI]
|
1.24943e-07
|
|
|
AR
|
[NCBI]
|
2.4947e-08
|
|